AuX Labs Raises $4 Million to Scale Animal-Free Cheese Protein

AuX Labs secured $4 million to scale its precision-fermented dairy protein and move animal-free cheese closer to pizzerias and cafes, a funding signal that suggests investors are rewarding familiar end products over abstract ingredient platforms. The Toronto company announced the round on April 21, 2026, with NYA Ventures and Nàdarra Ventures leading the deal and Verdex Capital and Builders VC also participating.

The raise matters because AuX Labs is not selling a futuristic idea in search of a use case. It is building around casein, the dairy protein that gives cheese much of its melt, stretch and taste, and it is pitching the ingredient where those traits are easiest to judge: on pizza, in café menus and in everyday foodservice. Ted Jin founded the company in 2021 and serves as chief executive, and AuX Labs has said the new capital will accelerate commercialization rather than simply extend laboratory development.

That commercial bent is reinforced by the company’s regulatory and customer progress. AuX Labs said its casein received self-affirmed GRAS status in April 2025, clearing a key step toward U.S. market access without waiting for a separate premarket food additive approval. The company had already been running customer pilots before the latest financing, which suggests the new money is meant to widen distribution and convert those trials into repeat business. A prior company profile said AuX Labs planned to begin selling ingredient products in early 2025, underscoring how closely the funding tracks with a go-to-market push.

Investors appear to be reading the category with discipline. One backer framed the business around unit economics, manufacturability and performance, a reminder that precision fermentation now has to prove it can make food at scale, not just in principle. That logic is especially clear in cheese, one of the hardest dairy categories to replace cleanly and one of the most obvious to consumers when it works. If AuX Labs can deliver reliable melt, stretch and flavor in pizzerias and cafes, it strengthens the case that animal-free dairy proteins belong in real menus, not just venture decks.

AuX Labs’ focus also fits a broader shift in precision fermentation. The category has long been sold on sustainability and animal welfare, but the companies drawing capital now are the ones tying those themes to concrete products buyers already understand. By centering on casein for cheese, AuX Labs is betting that commercializable familiarity is becoming the new funding filter.